FR2825024B1 - Identification de champignons parasites de l'organisme, et leur traitement - Google Patents

Identification de champignons parasites de l'organisme, et leur traitement

Info

Publication number
FR2825024B1
FR2825024B1 FR0106775A FR0106775A FR2825024B1 FR 2825024 B1 FR2825024 B1 FR 2825024B1 FR 0106775 A FR0106775 A FR 0106775A FR 0106775 A FR0106775 A FR 0106775A FR 2825024 B1 FR2825024 B1 FR 2825024B1
Authority
FR
France
Prior art keywords
parasites
fungus
organism
identification
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0106775A
Other languages
English (en)
Other versions
FR2825024A1 (fr
Inventor
Roumen Antonov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0106775A priority Critical patent/FR2825024B1/fr
Application filed by Individual filed Critical Individual
Priority to PL02367700A priority patent/PL367700A1/xx
Priority to IL15896702A priority patent/IL158967A0/xx
Priority to BR0209869-5A priority patent/BR0209869A/pt
Priority to EEP200300572A priority patent/EE200300572A/xx
Priority to CZ20033145A priority patent/CZ20033145A3/cs
Priority to EP02732883A priority patent/EP1389120B1/fr
Priority to PCT/FR2002/001739 priority patent/WO2002094287A2/fr
Priority to SK1437-2003A priority patent/SK14372003A3/sk
Priority to CNA02812510XA priority patent/CN1518451A/zh
Priority to NZ529764A priority patent/NZ529764A/en
Priority to KR10-2003-7015339A priority patent/KR20040018377A/ko
Priority to US10/478,508 priority patent/US20040198633A1/en
Priority to CA002448045A priority patent/CA2448045A1/fr
Priority to RU2003136777/15A priority patent/RU2003136777A/ru
Priority to HU0400035A priority patent/HUP0400035A2/hu
Publication of FR2825024A1 publication Critical patent/FR2825024A1/fr
Priority to NO20035188A priority patent/NO20035188D0/no
Priority to BG108375A priority patent/BG66299B1/bg
Priority to ZA200309122A priority patent/ZA200309122B/en
Publication of FR2825024B1 publication Critical patent/FR2825024B1/fr
Application granted granted Critical
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0106775A 2001-05-23 2001-05-23 Identification de champignons parasites de l'organisme, et leur traitement Expired - Fee Related FR2825024B1 (fr)

Priority Applications (19)

Application Number Priority Date Filing Date Title
FR0106775A FR2825024B1 (fr) 2001-05-23 2001-05-23 Identification de champignons parasites de l'organisme, et leur traitement
SK1437-2003A SK14372003A3 (sk) 2001-05-23 2002-05-23 Identifikácia parazitných plesní v organizme a ich liečenie
KR10-2003-7015339A KR20040018377A (ko) 2001-05-23 2002-05-23 유기체에서의 기생성 진균의 확인 및 그의 치료법
EEP200300572A EE200300572A (et) 2001-05-23 2002-05-23 Parasiitseente kindlakstegemine organismis ja nende töötlemine
CZ20033145A CZ20033145A3 (cs) 2001-05-23 2002-05-23 Identifikace parazitických plísní v organismu a jejich léčení
EP02732883A EP1389120B1 (fr) 2001-05-23 2002-05-23 Utilisation de la nystatine pour le traitement de l'athérosclérose liée à la présence de champignons parasites
PCT/FR2002/001739 WO2002094287A2 (fr) 2001-05-23 2002-05-23 Identification de champignons parasites de l'organisme, et traitement des maladies liees
IL15896702A IL158967A0 (en) 2001-05-23 2002-05-23 Identifying parasitic fungi of the organism, and treatment thereof
CNA02812510XA CN1518451A (zh) 2001-05-23 2002-05-23 生物体寄生真菌的鉴定和治疗
CA002448045A CA2448045A1 (fr) 2001-05-23 2002-05-23 Identification de champignons parasites de l'organisme, et leur traitement
PL02367700A PL367700A1 (en) 2001-05-23 2002-05-23 Identifying parasitic fungi of the organism, and treatment thereof
BR0209869-5A BR0209869A (pt) 2001-05-23 2002-05-23 Identificação de fungo parasìtico do organismo e seu tratamento
NZ529764A NZ529764A (en) 2001-05-23 2002-05-23 Identifying parasitic fungi of the organism, and treatment thereof
RU2003136777/15A RU2003136777A (ru) 2001-05-23 2002-05-23 Выявление паразитических грибов в организме и лечение связанных с ними патологий
HU0400035A HUP0400035A2 (hu) 2001-05-23 2002-05-23 A szervezet parazita gombáinak azonosítása és kezelése
US10/478,508 US20040198633A1 (en) 2001-05-23 2002-05-23 Identifying parasitic fungi of the organism, and treatment thereof
NO20035188A NO20035188D0 (no) 2001-05-23 2003-11-21 Identifikasjon av parasittiske fungi i organismen, og deres behandling
BG108375A BG66299B1 (bg) 2001-05-23 2003-11-21 Използване на противогъбични средства
ZA200309122A ZA200309122B (en) 2001-05-23 2003-11-24 Identifying parasitic fungi of the organism and treatment thereof.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0106775A FR2825024B1 (fr) 2001-05-23 2001-05-23 Identification de champignons parasites de l'organisme, et leur traitement

Publications (2)

Publication Number Publication Date
FR2825024A1 FR2825024A1 (fr) 2002-11-29
FR2825024B1 true FR2825024B1 (fr) 2005-06-24

Family

ID=8863577

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0106775A Expired - Fee Related FR2825024B1 (fr) 2001-05-23 2001-05-23 Identification de champignons parasites de l'organisme, et leur traitement

Country Status (1)

Country Link
FR (1) FR2825024B1 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5358959A (en) * 1993-02-18 1994-10-25 President And Fellows Of Harvard University Methods for treating arteriosclerosis

Also Published As

Publication number Publication date
FR2825024A1 (fr) 2002-11-29

Similar Documents

Publication Publication Date Title
CY2018020I1 (el) Θεραπεια της νοσου ρομρε
ATE472325T1 (de) Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
NO20041882L (no) Fremgangsmater for behandling av okulare neovaskulaere sykdommer.
DE60114808D1 (de) Oberflächenbehandlung von medizinischer vorrichtung
FR15C0070I2 (fr) Composes heteroaromatiques azotes pour le traitement des maladies de cancer
AU2002303295B2 (en) Diagnosis and treatment of neural disease and injury using microvoltammetry
MA25413A1 (fr) Fabrication de micromousse therapeutique.
IL158469A0 (en) Diagnosis, treatment, and research of mental disorder
EP1455778A4 (fr) Procedes de traitement de malaises neurovasculaires peripheriques
FR13C0060I2 (fr) Omega-carboxyaryldiphenyluree fluoro-subtituee pour le traitement et la prevention de maladies et d'etats pathologiques
NO20034430D0 (no) Tiohydantoiner og anvendelse derav for behandling av diatbetes
ATE384522T1 (de) Medikamente zur chemotherapeutischen behandlung von erkrankungen
DE60233265D1 (de) 5-sulfanyl-4h-1,2,4-triazolderivate und deren verwendung zur behandlung von somatostatine vermittelten krankheiten
DE60137337D1 (de) Vorbeugende und therapeutsche monoklonale antikörper gegen vacciniavirusantigene
NO20021964L (no) Biologisk fluidbehandling
DE60204466D1 (de) Integrinhemmer zur behandlung von augenkrankheiten
AU2002335794A1 (en) Allylamides useful in the treatment of alzheimer's disease
GB0019302D0 (en) Biological materials and the use thereof for the treatment of disease
NO20040659L (no) Isoksazolopyridinoner og andvendelse derav ved behandling av Parkinsons sykdom
EA200101260A1 (ru) Способ изменения физико-химических и/или биологических свойств вещества
DE60220220D1 (de) Blutbehandlungssystem
DE60016047D1 (de) Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
MA25852A1 (fr) Methode pour le traitement de l'inflammation.
FR2825024B1 (fr) Identification de champignons parasites de l'organisme, et leur traitement
NO20042476L (no) Anvendelse av desoxypeganin for behandling av klinisk depresjon

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20150130